Literature DB >> 912592

Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism.

M Davies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912592     DOI: 10.1007/bf02064043

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  11 in total

1.  EFFECTS OF SERUM CALCIUM LEVEL AND PARATHYROID EXTRACTS ON PHOSPHATE AND CALCIUM EXCRETION IN HYPOPARATHYROID PATIENTS.

Authors:  E EISENBERG
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

2.  The measurement and the meaning of urinary calcium.

Authors:  B E Nordin; A Hodgkinson; M Peacock
Journal:  Clin Orthop Relat Res       Date:  1967 May-Jun       Impact factor: 4.176

3.  Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

Authors:  M Garabedian; M F Holick; H F Deluca; I T Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

4.  1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.

Authors:  R G Russell; R Smith; R J Walton; C Preston; R Basson; R G Henderson; A W Norman
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

5.  Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

Authors:  R G Henderson; R G Russell; J G Ledingham; R Smith; D O Oliver; R J Walton; D G Small; C Preston; G T Warner
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

6.  The acute renal tubular effects of 1,25-dihydroxycholecalciferol.

Authors:  J B Puschett; P C Fernandez; I T Boyle; R W Gray; J L Omdahl; H F DeLuca
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

7.  Metabolic fate of administered 1,25-dihydroxycholecalciferol in controls and in patients with hypoparathyroidism.

Authors:  E B Mawer; J Backhouse; M Davies; L F Hill; C M Taylor
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

8.  Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.

Authors:  S W Kooh; D Fraser; H F DeLuca; M F Holick; R E Belsey; M B Clark; T M Murray
Journal:  N Engl J Med       Date:  1975-10-23       Impact factor: 91.245

9.  Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.

Authors:  R M Neer; M F Holick; H F DeLuca; J T Potts
Journal:  Metabolism       Date:  1975-12       Impact factor: 8.694

10.  Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.

Authors:  L F Hill; M Davies; C M Taylor; S W Standbury
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.